Европейский союз - мальтийский - EMA (European Medicines Agency)

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - aġenti antineoplastiċi - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.

Европейский союз - мальтийский - EMA (European Medicines Agency)

takeda manufacturing austria ag - octocog alfa - hemofilja a - sustanzi kontra l-emorraġija - trattament u profilassi ta 'fsada f'pazjenti b'emofilja a (nuqqas konġenitali ta' fattur viii). advate ma fihx il-fattur von willebrand fi kwantitajiet farmakoloġiċi effettivi u għaldaqstant mhuwiex indikat fil-mard ta ' von willebrand.

Европейский союз - мальтийский - EMA (European Medicines Agency)

n.v. organon - desloratadine, pseudophedrine sulfate - rinite allerġika staġjonali - preparazzjonijiet imnieħer - trattament sintomatiku ta 'rinite allerġika staġjonali meta jkun akkumpanjat minn konġestjoni nażali.

Европейский союз - мальтийский - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - aerius huwa indikat għas-serħan mis-sintomi assoċjati ma': rinite allerġika;urtikarja.

Европейский союз - мальтийский - EMA (European Medicines Agency)

glaxo group ltd - retapamulin - impetigo; staphylococcal skin infections - antibijotiċi u kimoterapewtiċi għal użu dermatoloġiku - short term treatment of the following superficial skin infections: , impetigo;, infected small lacerations, abrasions or sutured wounds. , ara sezzjonijiet 4. 4 u 5. 1 għal tagħrif importanti dwar l-attivita'klinika ta 'retapamulin kontra tipi differenti ta' staphylococcus aureus. għandha tingħata kunsiderazzjoni għall-gwida uffiċjali dwar l-użu xieraq ta ' sustanzi antibatteriċi.

Европейский союз - мальтийский - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.

Европейский союз - мальтийский - EMA (European Medicines Agency)

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - - ormoni tas-sess u modulaturi ta ' l-ġenitali-sistema, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Европейский союз - мальтийский - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - neoplasmi prostatiċi - terapija endokrinali - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Европейский союз - мальтийский - EMA (European Medicines Agency)

n.v. organon - desloratadine - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - anti-istaminiċi għall-użu sistemiku, - neoclarityn huwa indikat għas-serħan mis-sintomi assoċjati ma': allerġiċi rhinitisurticaria.

Европейский союз - мальтийский - EMA (European Medicines Agency)

glaxo group limited  - retigabine - epilessija - anti-epilettiċi, - trobalt huwa indikat bħala trattament adjunctive ta ' droga reżistenti b'sekwestru parzjali-iskoppjar bi jew mingħajr ġeneralizzazzjoni sekondarju fil-pazjenti li għandhom 18-il sena jew aktar bl-epilessija, fejn oħra tagħqid xieraq tad-droga, ġew ippruvati inadegwati jew ma jkunux ġew tollerat.